The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases

Tissue-based map of the human proteome

Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286 · see citing works

Chronic kidney disease

Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842 · see citing works

Diabetic Kidney Disease: Challenges, Progress, and Possibilities

Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11491116 · Cited by 2,898 · see citing works

US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States

Saran, R., Robinson, B. M., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J. Z., Balkrishnan, R., Bragg‐Gresham, J. L., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,192 · see citing works

g:Profiler—a web server for functional interpretation of gene lists (2016 update)

Reimand, J., Arak, T., Adler, P., Kolberg, L., Reisberg, S., Peterson, H., & Vilo, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw199 · Cited by 1,229 · see citing works

Diabetic kidney disease: a report from an ADA Consensus Conference

Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1296 · Cited by 1,153 · see citing works

Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014

Afkarian, M., Zelnick, L. R., Hall, Y. N., Heagerty, P. J., Tuttle, K., Weiss, N. S., & de Boer, I. H. (2016) · JAMA · doi:10.1001/jama.2016.10924 · Cited by 1,026 · see citing works

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121270 · Cited by 965 · see citing works

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein‐Fuchs, J., Hirsch, I. B., Kalantar‐Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 907 · see citing works

Mouse Models of Diabetic Nephropathy

Brosius, F. C., Alpers, C. E., Böttinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 898 · see citing works

Trends in Chronic Kidney Disease in China

Zhang, L., Long, J., Jiang, W., Shi, Y., He, X., Zhou, Z., Li, Y., Yeung, R. O., Wang, J., Matsushita, K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1602469 · Cited by 765 · see citing works

Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy

Elmarakby, A. A., & Sullivan, J. C. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 644 · see citing works

Reactive Oxygen Species-Regulated Signaling Pathways in Diabetic Nephropathy

Lee, H. B., Yu, M.-R., Yang, Y., Jiang, Z., & Ha, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077410.66390.0f · Cited by 468 · see citing works

Regulation of Connective Tissue Growth Factor Activity in Cultured Rat Mesangial Cells and Its Expression in Experimental Diabetic Glomerulosclerosis

Riser, B. L., DeNichilo, M. O., Cortés, P., Baker, C. J., Grondin, J. M., Yee, J., & Narins, R. G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11125 · Cited by 386 · see citing works

Suppression Subtractive Hybridization Identifies High Glucose Levels as a Stimulus for Expression of Connective Tissue Growth Factor and Other Genes in Human Mesangial Cells

Murphy, M., Godson, C., Cannon, S., Kato, S., Mackenzie, H. S., Martin, F., & Brady, H. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5830 · Cited by 384 · see citing works

Progression of diabetic nephropathy

Hovind, P. H., Rossing, P. R., Tarnow, L., Smidt, U., & Parving, H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002702.x · Cited by 383 · see citing works

A population-based study of the incidence and outcomes of diagnosed chronic kidney disease

Drey, N., Roderick, P. J., Mullee, M., & Rogerson, M. E. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00916-8 · Cited by 351 · see citing works

Progression of nephropathy in type 2 diabetic patients

Rossing, K., Christensen, P. K., Hovind, P. H., Tarnow, L., Rossing, P. R., & Parving, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00925.x · Cited by 338 · see citing works

Classification and Differential Diagnosis of Diabetic Nephropathy

Qi, C., Mao, X., Zhang, Z., & Wu, H. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8637138 · Cited by 301 · see citing works

Nephrology in China

Liu, Z.-H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.146 · Cited by 258 · see citing works

Predictors of Estimated GFR Decline in Patients with Type 2 Diabetes and Preserved Kidney Function

Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Negri, C., Stoico, V., & Bonora, E. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07650711 · Cited by 229 · see citing works

Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)

Thomas, M. C., MacIsaac, R. J., Jerums, G., Weekes, A., Moran, J. L., Shaw, J. E., & Atkins, R. C. (2009) · Diabetes Care · doi:10.2337/dc08-2186 · Cited by 216 · see citing works

Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy

Wang, S., DeNichilo, M. O., Brubaker, C. E., & Hirschberg, R. R. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00776.x · Cited by 207 · see citing works

A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy

Haneda, M., Utsunomiya, K., Koya, D., Babazono, T., Moriya, T., Makino, H., Kimura, K., Suzuki, Y., Wada, T., Ogawa, S., et al. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12319 · Cited by 190 · see citing works

Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury

Awad, A. S., You, H., Gao, T., Cooper, T. K., Nedospasov, S. A., Vacher, J., Wilkinson, P. F., Farrell, F. X., & Reeves, W. B. (2015) · Kidney International · doi:10.1038/ki.2015.162 · Cited by 189 · see citing works

Kidney function estimating equations: where do we stand?

Coresh, J., & Stevens, L. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000222695.84464.61 · Cited by 156 · see citing works

Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

Pedigo, C., Ducasa, G., Leclercq, F., Sloan, A., Mitrofanova, A., Hashmi, T., Molina-David, J., Ge, M., Lassenius, M., Forsblom, C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85939 · Cited by 156 · see citing works

Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes — United States and Puerto Rico, 2000–2014

Burrows, N. R., HORA, I. A., Geiss, L. S., Gregg, E. W., & Albright, A. L. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6643a2 · Cited by 154 · see citing works

A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy

Haneda, M., Utsunomiya, K., Koya, D., Babazono, T., Moriya, T., Makino, H., Kimura, K., Suzuki, Y., Wada, T., Ogawa, S., et al. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1057-z · Cited by 146 · see citing works

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy

Jorsal, A., Tarnow, L., Frystyk, J., Lajer, M., Flyvbjerg, A., Parving, H., Vionnet, N., & Rossing, P. R. (2008) · Kidney International · doi:10.1038/ki.2008.201 · Cited by 141 · see citing works

Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin–angiotensin–aldosterone system inhibition

Kim, M.-J., Frankel, A., Donaldson, M., Darch, S. J., Pusey, C. D., Hill, P. D., Mayr, M., & Tam, F. W. K. (2011) · Kidney International · doi:10.1038/ki.2011.224 · Cited by 133 · see citing works

Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice

Yokoi, H., Mukoyama, M., Mori, K., Kasahara, M., Suganami, T., Sawai, K., Yoshioka, T., Saito, Y., Ogawa, Y., Kuwabara, T., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002722 · Cited by 119 · see citing works

Recent Advancement of Understanding Pathogenesis of Type 1 Diabetes and Potential Relevance to Diabetic Nephropathy

Ichinose, K., Kawasaki, E., & Eguchi, K. (2007) · American Journal of Nephrology · doi:10.1159/000107758 · Cited by 113 · see citing works

Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy

Nguyen, T. Q., Tarnow, L., Jorsal, A., Oliver, N., Roestenberg, P., Ito, Y., Parving, H., Rossing, P. R., van Nieuwenhoven, F. A., & Goldschmeding, R. (2008) · Diabetes Care · doi:10.2337/dc07-2469 · Cited by 110 · see citing works

Diabetic nephropathy: landmark clinical trials and tribulations

Chan, G. C. W., & Tang, S. C. W. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu411 · Cited by 107 · see citing works

Diabetic Nephropathy

Suszták, K., & Böttinger, E. P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101109 · Cited by 101 · see citing works

Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential

Zha, D., Wu, X., & Gao, P. H. (2017) · Endocrinology · doi:10.1210/en.2016-1765 · Cited by 100 · see citing works

Mortality Rates in Trials of Subjects With Type 2 Diabetes

Barkoudah, E., Skali, H., Uno, H., Solomon, S. D., & Pfeffer, M. A. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000059 · Cited by 97 · see citing works

Nephrology in China

Lin, S. (2000) · Hong Kong Journal of Nephrology · doi:10.1016/s1561-5413(09)60038-7 · Cited by 92 · see citing works

Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy

Hovind, P. H., Tarnow, L., Rossing, P. R., Carstensen, B., & Parving, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00870.x · Cited by 90 · see citing works

Salutary Effect of Pigment Epithelium–Derived Factor in Diabetic Nephropathy

Wang, J. J., Zhang, S. X., Mott, R., Knapp, R. R., Cao, W., Lau, K., & Ma, J. (2006) · Diabetes · doi:10.2337/db05-1448 · Cited by 87 · see citing works

Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor

Li, D., Wang, N., Zhang, L., Hanyu, Z., Xueyuan, B., Fu, B., Shaoyuan, C., Zhang, W., Xuefeng, S., Li, R., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt314 · Cited by 86 · see citing works

Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy

Wang, J. J., Zhang, S. X., Mott, R., Chen, Y., Knapp, R. R., Cao, W., & Ma, J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00375.2007 · Cited by 85 · see citing works

Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression

Henger, A., Kretzler, M., Doran, P., Bonrouhi, M., Schmid, H., Kiss, É., Cohen, C. D., Madden, S. F., Porubský, Š., Gröne, E. F., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00499.x · Cited by 80 · see citing works

C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes

Liu, F., Chen, H., Huang, X., Chung, A. C. K., Zhou, L., Fu, P., Szalai, A. J., & Lan, H. Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2237-y · Cited by 74 · see citing works

Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes

Liu, Y., Zhang, J., Wang, Y., & Zeng, X. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.414 · Cited by 74 · see citing works

Cardiovascular Disease and Diabetic Kidney Disease

Maqbool, M., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.02.003 · Cited by 72 · see citing works

C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway

You, Y., Huang, X., Chen, H., Lyu, X., Liu, J., & Lan, H. Y. (2016) · Scientific Reports · doi:10.1038/srep26740 · Cited by 69 · see citing works

Accurate Estimation of Glomerular Filtration Rate in Diabetic Nephropathy From Age, Body Weight, and Serum Creatinine

Sampson, M., & Drury, P. (1992) · Diabetes Care · doi:10.2337/diacare.15.5.609 · Cited by 57 · see citing works

Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis

Maeda, S., Matsui, T., Takeuchi, M., Yoshida, Y., Yamakawa, R., Fukami, K., & Yamagishi, S. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.11.008 · Cited by 55 · see citing works

Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-κB activation

Ide, Y., Matsui, T., Ishibashi, Y., Takeuchi, M., & Yamagishi, S. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.03.015 · Cited by 52 · see citing works

Mortality Rates in Trials of Subjects With Type 2 Diabetes

Barkoudah, E., Skali, H., Uno, H., et al. (2012) · Journal of the American Heart Association · doi:10.1161/xjaha.111.000059 · Cited by 51 · see citing works

Visfatin is upregulated in type-2 diabetic rats and targets renal cells

Kang, Y. S., Song, H. K., Lee, M., Ko, G. J., Han, J., Han, S. Y., Han, K. H., Kim, H. K., & Cha, D. R. (2010) · Kidney International · doi:10.1038/ki.2010.98 · Cited by 47 · see citing works

Urinary Adiponectin Is an Independent Predictor of Progression to End-Stage Renal Disease in Patients With Type 1 Diabetes and Diabetic Nephropathy

Panduru, N. M., Saraheimo, M., Forsblom, C. M., Thorn, L. M., Gordin, D., Wadén, J., Tolonen, N., Bierhaus, A., Humpert, P. M., & Groop, P. (2015) · Diabetes Care · doi:10.2337/dc14-2276 · Cited by 39 · see citing works

A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy

Haneda, M., Utsunomiya, K., Koya, D., Babazono, T., Moriya, T., Makino, H., Kimura, K., Suzuki, Y., Wada, T., Ogawa, S., et al. (2014) · Diabetology International · doi:10.1007/s13340-014-0197-4 · Cited by 38 · see citing works

Urinary miR-196a predicts disease progression in patients with chronic kidney disease

Zhang, C., Liang, S., Cheng, S., Li, W., Wang, X., Zheng, C., Zeng, C., Shi, S., Xie, L., Zen, K., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1470-2 · Cited by 37 · see citing works

An integrative systems biology approach for precision medicine in diabetic kidney disease

Mulder, S. T., Hamidi, H., Kretzler, M., & Ju, W. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13416 · Cited by 36 · see citing works

Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II

Guo, X., Zhou, G., Guo, M., Cheung, A. K., Huang, Y., & Beddhu, S. (2014) · Physiological Reports · doi:10.1002/phy2.230 · Cited by 31 · see citing works

Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria

von Scholten, B. J., Reinhard, H., Hansen, T. W., Oellgaard, J., Parving, H., Jacobsen, P. K., & Rossing, P. R. (2016) · Diabetologia · doi:10.1007/s00125-016-3937-0 · Cited by 27 · see citing works

Genetics of Diabetic Kidney Disease—From the Worst of Nightmares to the Light of Dawn?

Ronald, C. W., & Cooper, M. E. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016091028 · Cited by 24 · see citing works

Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes

Wang, B., Carter, R. E., Jaffa, M. A., Nakerakanti, S. S., Lackland, D. T., Lopes-Virella, M. F., Trojanowska, M. E., Luttrell, L. M., Jaffa, A. A., & The DCCT/EDIC Study Group (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.073098 · Cited by 24 · see citing works

Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy

An, Y., Zhang, C., Xu, F., Li, W., Zeng, C., Xie, L., & Liu, Z. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy326 · Cited by 22 · see citing works

C-Reactive Protein Induces Interleukin-6 and Thrombospondin-1 Protein and mRNA Expression through Activation of Nuclear Factor-ĸB in HK-2 Cells

Wang, H., Chen, D.-L., Zhao, M., Shu, S.-W., Xiong, S., Gan, X., Chao, S.-P., & Cao, J. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000332402 · Cited by 21 · see citing works

Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy

Wang, L.-X., Wang, N., Qingli, X., Yan, W., Li, D., & Li, B. (2017) · Bioscience Reports · doi:10.1042/bsr20160544 · Cited by 6 · see citing works

Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose-response study and open-label extension study

Wada, T., Inagaki, M., Yoshinari, T., Terata, R., Totsuka, N., Gotou, M., & Hashimoto, G. (2021) · Clinical and Experimental Nephrology · doi:10.1007/s10157-020-01963-z · Cited by 97 · see citing works

Icariin ameliorates streptozocin-induced diabetic nephropathy through suppressing the TLR4/NF-κB signal pathway

Qi, M.-Y., He, Y., Cheng, Y., Fang, Q., Ma, R., Zhou, S.-J., & Hao, J. (2021) · Food & Function · doi:10.1039/d0fo02335c · Cited by 82 · see citing works

Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology

Guo, M., Dai, Y., Gao, J., & Chen, P. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5947304 · Cited by 76 · see citing works

Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study

Smyth, L. J., Kilner, J., Nair, V., Liu, H., Brennan, E. P., Kerr, K., Sandholm, N., Cole, J. B., Dahlström, E. H., Syreeni, A., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01081-x · Cited by 59 · see citing works

The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study

Hu, Y., Qing-e, L., Min, R., Deng, Y., Xu, Y., & Gao, L. (2021) · PeerJ · doi:10.7717/peerj.10691 · Cited by 46 · see citing works

Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management

Kong, A. P. S., Lim, S. K., Yoo, S.-H., Ji, L., Chen, L., Bao, Y., Yeoh, E. C. K., Chan, S.-P., Wang, C., Mohan, V., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110718 · Cited by 48 · see citing works

Protective effects of Radix Pseudostellariae polysaccharides against exercise-induced oxidative stress in male rats

Chen, Z., Li, S., Wang, X., & Zhang, C. L. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.942 · Cited by 39 · see citing works

Diagnostic value of VDBP and miR‑155‑5p in diabetic nephropathy and the correlation with urinary microalbumin

Bai, X., Luo, Q., Tan, K., & Guo, L. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9214 · Cited by 34 · see citing works

Incidence of Diabetic Nephropathy and Its Predictors among Type 2 Diabetes Mellitus Patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

Kebede, S. A., Tusa, B. S., Weldesenbet, A. B., Tessema, Z. T., & Ayele, T. A. (2021) · Journal of Nutrition and Metabolism · doi:10.1155/2021/6757916 · Cited by 31 · see citing works

Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases

Li, G., Kidd, J. M., & Li, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051559 · Cited by 29 · see citing works

IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration

Yu, K., Li, D., Xu, F., Guo, H., Feng, F., Ding, Y., Wan, X., Sun, N., Zhang, Y., Fan, J., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107446 · Cited by 27 · see citing works

Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis

Gallieni, M. A., Salvo, C. D., Lunati, M. E., Rossi, A., D’Addio, F., Pastore, I., Sabiu, G., Miglio, R., Zuccotti, G., & Fiorina, P. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01699-6 · Cited by 27 · see citing works

Identification of Hub Genes and Potential ceRNA Networks of Diabetic Nephropathy by Weighted Gene Co-Expression Network Analysis

Li, G., Zhang, J., Liu, D., Wei, Q., Wang, H., Lv, Y., Ye, Z., Liu, G., & Li, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.767654 · Cited by 27 · see citing works

Polymer-Based Delivery of Peptide Drugs to Treat Diabetes: Normalizing Hyperglycemia and Preventing Diabetic Complications

Jeon, H., Lee, A.-J., & Ha, K. (2022) · BioChip Journal · doi:10.1007/s13206-022-00057-0 · Cited by 25 · see citing works

A network pharmacology approach to explore the mechanism of HuangZhi YiShen Capsule for treatment of diabetic kidney disease

Zhou, X., Zhou, W., Liu, W., Luo, M., Wu, X., Wang, Y., Liu, P., Wen, Y., Li, J., Zhao, T., et al. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0020 · Cited by 24 · see citing works

Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy

Ma, Y., Deng, Y., Li, N., Dong, A., Li, H., Chen, S., Zhang, S., & Zhang, M. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115768 · Cited by 24 · see citing works

Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials

Guo, H.-B., Peng, J., Wang, X., Zhang, K.-K., Zhong, G.-Z., Chen, W., & Shi, G.-X. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02487-8 · Cited by 25 · see citing works

Machine learning-based risk predictive models for diabetic kidney disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis

Li, Y., Jin, N., Zhan, Q., Huang, Y., Sun, A., Yin, F., Li, Z., Hu, J., & Liu, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1495306 · Cited by 22 · see citing works

Determining the influence of high glucose on exosomal lncRNAs, mRNAs, circRNAs and miRNAs derived from human renal tubular epithelial cells

Zhou, S., Fang, J., Hu, M., Pan, S., Liu, D., Xing, G., & Liu, Z. (2021) · Aging · doi:10.18632/aging.202656 · Cited by 21 · see citing works

WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy

Hashemi, E., Dehghanbanadaki, H., Baharanchi, A. A., Forouzanfar, K., Kakaei, A., Mohammadi, S. M., Zeidi, S., & Razi, F. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02964-6 · Cited by 21 · see citing works

Ellagic acid inhibits high glucose‑induced injury in rat mesangial cells via the PI3K/Akt/FOXO3a signaling pathway

Lin, W., Liu, G., Kang, X., Guo, P., Shang, Y., Du, R., Wang, X., Chen, L., Yue, R., Kong, F., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10449 · Cited by 21 · see citing works

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice

Wang, P., Guo, R., Bai, X., Cui, W., Zhang, Y., Li, H., Shang, J., & Zhao, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1034818 · Cited by 21 · see citing works

Dysregulation of Extracellular Matrix in Diabetic Complications: Clinical Impacts and New Molecular Targets

Khan, M. S., Jeon, Y., Lee, C., Yang, J. M., & Kim, S. G. (2025) · Innovations in Acupuncture and Medicine · doi:10.1186/s44424-025-00005-3 · Cited by 20 · see citing works

Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT

Cho, A., Jin, W., Lee, J., Shin, N., Lee, M. S., Li, L., Yang, S. H., Park, K. S., Yang, C. W., Kim, D. K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44177-5 · Cited by 19 · see citing works

Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking

Yao, T., Wang, Q., Han, S., Lu, Y., Xu, Y., & Wang, Y. (2022) · BioMed Research International · doi:10.1155/2022/9214589 · Cited by 18 · see citing works

Astragaloside I from Astragalus Attenuates Diabetic Kidney Disease by Regulating HDAC3/Klotho/TGF-β1 Loop

Zhang, X., Wang, J., Xiang, S., Zhao, L., Lv, M., Duan, Y., Gao, G., Wang, P., Chen, J. J., Xu, J., et al. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500708 · Cited by 17 · see citing works

Interplay between long non-coding RNA MALAT1 and pyroptosis in diabetic nephropathy patients

Shoeib, H. M., Keshk, W. A., Alghazaly, G. M., Wagih, A., & El-Dardiry, S. A. (2022) · Gene · doi:10.1016/j.gene.2022.146978 · Cited by 16 · see citing works

Transglutaminase 2 in diabetes mellitus: Unraveling its multifaceted role and therapeutic implications for vascular complications

Ha, K. (2024) · Theranostics · doi:10.7150/thno.95742 · Cited by 15 · see citing works

Midazolam Ameliorates Hyperglycemia-Induced Glomerular Endothelial Dysfunction by Inhibiting Transglutaminase 2 in Diabetes

Seo, J.-A., Danishmalik, S. N., Lee, Y., Jeon, H., Kim, E.-B., Hong, S., Cho, S., Kim, M., & Ha, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020753 · Cited by 15 · see citing works

SIRT2 Affects Cell Proliferation and Apoptosis by Suppressing the Level of Autophagy in Renal Podocytes

Liu, S., Gao, X., Fan, Z., & Wang, Q. (2022) · Disease Markers · doi:10.1155/2022/4586198 · Cited by 14 · see citing works

Shen-Qi-Jiang-Tang granule ameliorates diabetic nephropathy via modulating tumor necrosis factor signaling pathway

Chen, M., Jia, J.-H., Tan, Y., Ren, Y., Lv, J.-L., Chu, T., Cao, X.-Y., Ma, R., Li, D.-F., Zheng, Q., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116031 · Cited by 13 · see citing works

Incidence and predictors of chronic kidney disease among patients with diabetes treated at governmental hospitals of Harari Region, eastern Ethiopia, 2022

Cheru, A., Edessa, D., Regassa, L. D., & Gobena, T. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1290554 · Cited by 13 · see citing works

The Heritability of Kidney Function Using an Older Australian Twin Population

Jefferis, J., Pelecanos, A. M., Catts, V. S., & Mallett, A. J. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.05.012 · Cited by 13 · see citing works

Quality of Evidence Supporting the Role of Tripterygium Glycosides for the Treatment of Diabetic Kidney Disease: An Overview of Systematic Reviews and Meta-Analyses

Shi, H., Deng, P., Dong, C., Lu, R., Si, G., & Yang, T. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s367624 · Cited by 12 · see citing works

Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications

Kaur, P., Dahiya, R., Nandave, M., Sharma, K., & Goyal, R. K. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4037 · Cited by 12 · see citing works

Prevalence of nephropathy among patients with diabetes mellitus in Africa: a systematic review and meta-analysis

Adebayo-Gege, G. I., Adegbola, P. I., Adedayo, L. D., Oyefabi, A. M., Oyeyemi, I. T., Odeniran, O. A., Oke, A., Okeke, O. P., Abodunrin, O. R., Akinsolu, F. T., et al. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1551088 · Cited by 12 · see citing works

The role of Elabela in kidney disease

Zheng, Q., Tian, G., Xu, F., Ci, X., Luan, R., Wu, L., & Lu, X. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-02790-1 · Cited by 12 · see citing works

Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients

Darmayanti, S., Lesmana, R., Meiliana, A., & Abdulah, R. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210101105253 · Cited by 11 · see citing works

Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose‐Induced Podocyte Injury by Inhibiting the Activation of Wnt/β‐Catenin Signaling Pathway, Resulting in Activation of Podocyte Autophagy

Dai, H., Liu, F., Qiu, X., Liu, W., Dong, Z., Jia, Y., Feng, Z., Liu, Z., Zhao, Q., Gao, Y., et al. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7809427 · Cited by 10 · see citing works

GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Leprdb/db mice

Meng, Q., Tian, X., Li, J., Pruekprasert, N., Dhawan, R., Holz, G. G., & Cooney, R. N. (2022) · Scientific Reports · doi:10.1038/s41598-022-27015-y · Cited by 10 · see citing works

Exploring the pharmacological mechanisms of Tripterygium wilfordii against diabetic kidney disease using network pharmacology and molecular docking

Lu, M., Ou, J., Deng, X., Chen, Y., & Gao, Q. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17550 · Cited by 9 · see citing works

Exploring the Molecular Mechanism of Liuwei Dihuang Pills for Treating Diabetic Nephropathy by Combined Network Pharmacology and Molecular Docking

Wang, G., Zeng, L., Huang, Q., Lu, Z., Sui, R., Liu, D., Zeng, H., Liu, X., Chu, S., Kou, X., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/7262208 · Cited by 9 · see citing works

The effects of melatonin administration on carotid intima-media thickness and pulse wave velocity in diabetic nephropathy: A randomized, double-blind, placebo-controlled trial

Talari, H. R., Tabatabaei, S. M. H., Soleimani, A., Sayyah, M., & Bozorgi, M. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.01.002 · Cited by 8 · see citing works

Effects of Glycemic Variability on Regulatory T Cells in Patients with Type 2 Diabetes and Kidney Disease

Gu, Q., Sun, Q., Wang, J., Gu, W., Wang, W., & Mao, X. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s413407 · Cited by 8 · see citing works

Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy

Joshi, H. R., Vastrad, B. M., Joshi, N., & Vastrad, C. M. (2022) · SAGE Open Medicine · doi:10.1177/20503121221137005 · Cited by 8 · see citing works

Correlation between Serum Bone Turnover Markers and Estimated Glomerular Filtration Rate in Chinese Patients with Diabetes

Zhu, X., Zhou, Y., Hong, S., Xue, Y., & Cui, Y. (2021) · Disease Markers · doi:10.1155/2021/6731218 · Cited by 8 · see citing works

Fisiopatologia e diagnóstico da nefropatia diabética: uma revisão integrativa / Physiopathology and diagnosis of diabetic nephropathy: an integrative review

Azevedo, G., Felizardo, J. R., Moser, M. P., & Savi, D. C. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n1-313 · Cited by 7 · see citing works

Screening and identification of key microRNAs and regulatory pathways associated with the renal fibrosis process

Li, X., Dong, Z., Chang, H., Zhou, H., Wang, J., Yang, Z.-J., Qiu, M., Bai, W., & Shi, S. (2022) · Molecular Omics · doi:10.1039/d1mo00498k · Cited by 7 · see citing works

Developing and validating a prognostic prediction model for patients with chronic kidney disease stages 3–5 based on disease conditions and intervention methods: a retrospective cohort study in China

Zhang, M., Lei, N., Zhang, X., Xu, Y., Chen, H.-F., Fu, L., Tang, F., Liu, X., & Wu, Y. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054989 · Cited by 7 · see citing works

Assessment of microvascular function using a novel technique Flow Mediated Skin Fluorescence (FMSF) in patients with diabetic kidney disease: A preliminary study

Łoś-Stegienta, A., Borkowska, A., & Cypryk, K. (2022) · Microvascular Research · doi:10.1016/j.mvr.2022.104417 · Cited by 7 · see citing works

LAOS: Layered WWW AHS Authoring Model with Algebraic Operators.

Cristea, A. I., & Mooij, A. D. (2003) · Cited by 7 · see citing works

Circulating inflammatory factors and risk causality associated with type 2 diabetic nephropathy: A Mendelian randomization and bioinformatics study

Hu, J., Dong, X. Y., Yao, X., & Yi, T.-N. (2024) · Medicine · doi:10.1097/md.0000000000038864 · Cited by 6 · see citing works

Predictive model combining blood pressure, glycemic and renal markers for diabetic nephropathy in elderly hypertensive patients with type 2 diabetes

Guo, F., Qin, L., Chen, B., Xu, H., Wang, J., An, R., & Zhang, Q. (2025) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2025.2564299 · Cited by 5 · see citing works

Glycemic control outcome in patients with type 2 diabetes mellitus: chronic care management support of family care team in Thailand

Wongrith, P., Thirarattanasunthon, P., & Kaewsawat, S. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00851-x · Cited by 5 · see citing works

Comprehensive analyses of the microRNA–messenger RNA–transcription factor regulatory network in mouse and human renal fibrosis

Deng, L., Xu, G., & Huang, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.925097 · Cited by 5 · see citing works

AMPK as a central regulator of metabolic memory: mechanisms and therapeutic opportunities

Khan, W. A., Garg, S. S., Banyal, K., & Gupta, J. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01859-x · Cited by 4 · see citing works

Loss of glomerular aldolase B in diabetic nephropathy promotes renal fibrosis via activating Akt/GSK/β-catenin axis

Liu, M., Yang, W., Qu, S., Zhao, T., Jiang, S., Peng, S., Zhang, M., Xuan, J., Liu, Z., & Ke, Z. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.027 · Cited by 4 · see citing works

CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications

Leilei, M., Bin, H., Li, R., & Wen, W. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04314-w · Cited by 4 · see citing works

Establishment and validation of a diagnostic model for diabetic nephropathy in type 2 diabetes mellitus

Xing, Y., Chai, X.-J., Liu, K., Cao, G., & Wei, G. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03815-7 · Cited by 4 · see citing works

Determinants of diabetic nephropathy among adult diabetic patients on follow-up at public hospitals in Addis Ababa, Ethiopia: A case-control study

Tola, D. E., Bayissa, Z. B., Desissa, T. A. T. A., Solbana, L. K., Tesfaye, A. H., & Eba, B. F. (2024) · SAGE Open Medicine · doi:10.1177/20503121231218890 · Cited by 4 · see citing works

New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203

Eroğlu, I., Korkmaz, H., Öztürk, K. H., Şirin, F. B., ŞEVİK, S., & Afşar, B. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03204-6 · Cited by 4 · see citing works

NRF2: A potential target for the treatment of diabetic nephropathy

Zhang, J., Anshul, F., Breidenbach, J. D., Liu, J., & Shaffner, J. (2021) · Diabetic Nephropathy · doi:10.2478/dine-2021-0006 · Cited by 3 · see citing works

Risk prediction of nephropathy by integrating clinical and genetic information among adult patients with type 2 diabetes

Liao, L.-N., Li, T., Yeh, C., Li, C., Liu, C.-S., Yang, C., Yang, Y.-F., Lin, C., Tsai, F.-J., & Lin, C. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-02017-4 · Cited by 3 · see citing works

Effect of suramin on urinary excretion of diabetes-induced glomerular and tubular injury parameters in rats

Sałaga-Zaleska, K., Pikuł, P., Kreft, E., Herman, S., Chyła-Danił, G., Dąbkowski, K., Kuchta, A., Lenartowicz, M., & Jankowski, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111683 · Cited by 3 · see citing works

Nanosuspension-based drug delivery system for management of diabetes and its complications: a review

Saini, A., Nagar, L., Dua, K., Dureja, H., Pahwa, R., & Verma, P. K. (2025) · Macromolecular Research · doi:10.1007/s13233-025-00441-3 · Cited by 2 · see citing works

Causal relationship between obstructive sleep apnea and diabetic nephropathy: bidirectional and multivariable Mendelian randomization study

Zhao, L. D., Liu, Z., Zhang, R., Li, Y., & Zhang, X. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2569086 · Cited by 2 · see citing works

Osteoinductive Factor and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: A Literature Review

Ramadan, A. (2022) · Sohag Medical Journal · doi:10.21608/smj.2022.131430.1315 · Cited by 2 · see citing works

The Predictive Value of Melatonin Levels for the Development of Diabetic Nephropathy in Men with Type 2 Diabetes Mellitus

Al-temimi, R. B., Ibrahim, N. N., Nazar, L. A., Hasan, H. A., Al‐Musawi, M. H., & Moghadam, F. M. (2024) · Reports of Biochemistry and Molecular Biology · doi:10.61186/rbmb.13.3.341 · Cited by 2 · see citing works

“Evaluation of Anti-Inflammatory Effects of Allopurinol in Diabetic Patients with Chronic Kidney Disease (DM-CKD): A Clinical Study”Preprint

Daniyali, M., Mahmoudieh, L., Afzal, G. S., Hematian, F., Moradi, O., & Ziaie, S. (2021) · Research Square · doi:10.21203/rs.3.rs-585871/v1 · Cited by 2 · see citing works

Risk factors for diabetic nephropathy among newly diagnosed type 2 diabetic patients with normal blood pressure

Zaman, S., Rahim, M. A., & Habib, S. H. (2022) · BIRDEM Medical Journal · doi:10.3329/birdem.v12i2.59624 · Cited by 1 · see citing works

Identification of key immune-related genes and potential therapeutic drugs in diabetic nephropathy based on machine learning algorithms

Guo, C. Y., Wang, W. J., Dong, Y., & Han, Y. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01995-4 · Cited by 2 · see citing works

Identification of Immune-Related Ferroptosis Biomarkers in Diabetic Kidney Disease and Screening of Associated Inhibitors

Zhang, N.-N., Zhu, Y., Huang, Q., Hu, F., Li, J., & Yang, X. (2025) · Current Medical Science · doi:10.1007/s11596-025-00091-7 · Cited by 1 · see citing works

Correlation of CRP/HDL-C ratio with diabetic kidney disease in type 2 diabetes mellitus patients: evidence from the NHANES 2015–2020

Wu, T., Gu, T., Wang, Q., Li, Y., Chen, X., Shen, S., & Xia, Y. (2026) · Journal of Laboratory Medicine · doi:10.1515/labmed-2025-0256 · Cited by 1 · see citing works

Complement 3a and Complement 5a as Biochemical Markers in Diabetic Nephropathy

Ahmed, S. F., Alsayed, A. M. R., Aref, M. I. A. I., & Alkot, A. M. F. (2024) · International Journal of Medical Arts · doi:10.21608/ijma.2024.255133.1887 · Cited by 1 · see citing works

MicroRNA Databases

Hansel-Frose, A., Friedrichs, M., & Allmer, J. (2024) · Epigenetics and human health · doi:10.1007/978-3-031-64788-8_2 · Cited by 1 · see citing works

Association of diabetic nephropathy with diabetic retinopathy in type 2 diabetes mellitus patients

Mohan, C., Muthukrishnan, J., Mishra, S. K., & Nair, B. T. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20195568 · Cited by 1 · see citing works

Effect of Danggui-Shaoyao-San on renal macrophages in STZ-induced DN rats

Li, X., Miao, X., Wang, L., Zhang, W., Fu, C., Zhao, M., Chen, W., Cai, R., Chen, Y., & Hou, L. (2020) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2020.01.016 · Cited by 1 · see citing works

Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in diabetic nephropathyPreprint

Joshi, H. R., Vastrad, B. M., Joshi, N., Tengli, A., Vastrad, C. M., & Kotturshetti, I. (2020) · Research Square · doi:10.21203/rs.3.rs-132705/v1 · Cited by 1 · see citing works

Efficacy of Tripterygium Glycosides for Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled TrialsPreprint

Guo, H.-B., Guo, H.-B., Peng, J.-Q., Zhang, K.-K., Zhong, G.-Z., Chen, W., & Shi, G.-X. (2021) · doi:10.21203/rs.3.rs-194899/v1 · Cited by 1 · see citing works

STUDY OF PREVALENCE AND CLINICAL PROFILE OF NEPHROPATHY AND RETINOPATHY IN TYPE 2 DIABETES PATIENTS AT TERTIARY CARE CENTER, UDAIPUR

Patel, Y. (2021) · GLOBAL JOURNAL FOR RESEARCH ANALYSIS · doi:10.36106/gjra/0100380

Elevated TBC1D1 defined immunosuppressive microenvironment and poor prognosis in low-grade gliomaPreprint

Song, D., Liu, J., Wei, Y., Chen, Y., Luan, T., Wang, X., Feng, R., Zhang, Z., Zhang, C., Qiu, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1929994/v1

Gender disparity in prevalence and risk factors of chronic Kidney disease among patients with type 2 diabetes in Northeastern Nigeria.

Mohammmed, S. M., Lawan, M., Loskurima, U., Ibrahim, U., Ijiftur, C. K., Ahidivu, M., Abubakar, T., Abdullahi, A. O., Ndahi, A. A., & Jumai, S. (2021) · Kanem Journal of Medical Sciences · doi:10.36020/kjms.2022.1502.004

Determinants of diabetic nephropathy among diabetic patients attending in Tikur Anbesa specialized hospital, Addis Abeba, Ethiopia

Tesfahun, E., Mulatu, K., Deresse, T., & Mulugeta, B. (2023) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2023.101481

Prevalence, Incidence, and Risk Factors of Nephropathy in Patients with Prediabetes: Family History of Diabetes Mellitus Is Not Associated with Increased Risk of Nephropathy

Abbasi, S., Amini, M., Vahdat, S., Aminorroaya, A., Mortazavi, M., & Azimi, F. (2024) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc-142750

Diabetic Nephropathy in Advanced Age Patients

Argyropoulos, C., & Roumelioti, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-68460-9_8

Evaluation of serum Cystatin C as a predictor of eGFR in type 2 diabetic patients with nephropathy

Fatima, A., Mal, P., Memon, Z. R., Kumar, M., Memon, H. J., & Fatima, M. (2025) · Journal of Shalamar Medical & Dental College - JSHMDC · doi:10.53685/jshmdc.v6i1.294

Metagenomic profiling of gut microbiome: associating their role with the advancement of diabetic nephropathy

Bhatt, P., Rajesh, P., Kukkar, D., & Kim, K. (2025) · Antonie van Leeuwenhoek · doi:10.1007/s10482-025-02141-5 · Cited by 1 · see citing works

Renal Function Alterations Associated with Diabetes: A Study Conducted in Dakhla

Hammou, R. A., Louragli, I., & Caid, M. B. E. (2025) · BIO Web of Conferences · doi:10.1051/bioconf/202520001010

ALOX5, a novel diagnostic and prognostic marker associated with immune cells and ferroptosis in diabetic kidney diseasePreprint

Zhang, N., Zhu, Y., fei, H., An, M., Yang, X., Li, J., & Li, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3744360/v1

The role of some biochemical markers in the pathogenesis of diabetic nephropathy

Raffik, D. E., Ahmed, A. H., & Raoof, A. A. (2026) · AIP conference proceedings · doi:10.1063/12.0042913

α-Hederin Mitigates Streptozotocin-induced Diabetic Nephropathy in Rats via Regulating Physiological Changes, Inflammation, and Oxidative Stress Responses

Zhang, Q., Zhang, L., Li, C., Tian, L., Guo, S., & Liu, X. (2026) · Pharmacognosy Magazine · doi:10.1177/09731296261462768

Plant-Derived Flavonoids Ameliorate Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Potential

Tang, E., Huang, S., Zhou, H., Liao, W., & Zhang, Z. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100741

Gene and protein markers of diabetic nephropathy

Granier, C., Makni, K., Molina, L., Jardin-Watelet, B., Ayadi, H., & Jarraya, F. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm834 · Cited by 32 · see citing works

Research progress on biomarkers of progression of diabetic nephropathy

Zi-yi, W., & 戴恩来 (2020) · DOAJ (DOAJ: Directory of Open Access Journals)

Development of a nomogram for predicting renal survival in patients with biopsy-proven diabetic nephropathy

Lin, Z., Hong, T., Wang, W., Xie, S., Zhang, X., Xuan, T., Yang, F., Chen, C., Jiang, D., Wan, J., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1532494 · Cited by 6 · see citing works

Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy

Campion, C. G., Sanchez-Ferras, O., & Batchu, S. N. (2017) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358117705371 · Cited by 151 · see citing works

A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease

Agarwal, R., Duffin, K. L., Laska, D. A., Voelker, J. R., Breyer, M. D., & Mitchell, P. G. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu255 · Cited by 75 · see citing works